AI Health Coach Lowers Blood Pressure and Boosts Engagement in Patients with Hypertension

A new study in JMIR Cardio, published by JMIR Publications, shows that a fully digital, artificial intelligence (AI)-driven lifestyle coaching program can effectively reduce blood pressure (BP) in adults with hypertension. This AI-based program leverages data from wearable activity trackers and BP monitors as well as a mobile app questionnaire to tailor lifestyle guidance. The research team, led by Jared Leitner of the University of California, San Diego, used this innovative intervention to help manage hypertension and enhance patient engagement, offering a promising alternative to traditional coaching models.

The researchers employed a single-arm nonrandomized trial to evaluate the effects of the program's personalized lifestyle guidance, which was delivered to 141 participants through SMS text messages and a mobile app. Over 24 weeks, participants with stage 2 hypertension showed significant reductions in both systolic and diastolic BP. At 12 weeks, systolic BP decreased by an average of 9.6 mm Hg and diastolic BP by 5.7 mm Hg. These reductions were even more pronounced at 24 weeks, with systolic BP dropping by 14.2 mm Hg and diastolic BP by 8.1 mm Hg.

This precision coaching program led to an increase in participants achieving BP control and a decrease in participants with stage 2 hypertension. The study also highlighted high participant engagement and minimal need for manual clinician outreach. This indicates that the AI-driven approach not only enhances BP control but also substantially reduces the workload for health care providers.

"By pinpointing the top lifestyle contributors to patients' hypertension and providing precise guidance, the AI-powered lifestyle coaching was able to maintain high patient engagement leading to improved patient outcomes. This study demonstrates how an AI-based, autonomous approach to hypertension-related lifestyle coaching can increase scalability and accessibility to effective blood pressure management," remarked Dr. Leitner.

This research underscores the potential for digital health innovations to transform hypertension management, providing scalable, cost-effective, and personalized care options for patients.

Leitner J, Chiang PH, Agnihotri P, Dey S.
The Effect of an AI-Based, Autonomous, Digital Health Intervention Using Precise Lifestyle Guidance on Blood Pressure in Adults With Hypertension: Single-Arm Nonrandomized Trial.
JMIR Cardio. 2024 May 28;8:e51916. doi: 10.2196/51916

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...